Samsung Biologics targets 15 banks for W3tr IPO

GLOBALCAPITAL INTERNATIONAL LIMITED, a company

incorporated in England and Wales (company number 15236213),

having its registered office at 4 Bouverie Street, London, UK, EC4Y 8AX

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Asia

Samsung Biologics targets 15 banks for W3tr IPO

Jonathan Breen
May 06, 2016 05:15 AM
samsung_flags_230px

Samsung Biologics, which sent out a request for proposals for its South Korean IPO on April 29, is understood to have invited nine domestic and six international firms to submit bids.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganCredit SuisseEquity IPOsEquityKDB Daewoo SecuritiesBank of AmericaKorea Investment and SecuritiesCitiSouth KoreaAsiaMorgan StanleyKookmin BankEmerging MarketsGoldman Sachs
JB
Jonathan Breen
Equities editor GlobalCapital Asia
Contact
Gift this article